FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/062057 [Registered on: 30/01/2024] Trial Registered Prospectively
Last Modified On: 07/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Process of Care Changes
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Impact of early prolonged Kangaroo Mother Care on normal birth weight infants. 
Scientific Title of Study   Can Kangaroo Mother Care (KMC) during the first 72 hours lead to improved breastfeeding and growth among normal birth weight newborns? - A randomized controlled trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aarti Kumar 
Designation  CEO and Principal Scientist 
Affiliation  Community Empowerment Lab 
Address  Community Empowerment Lab 1st Floor, CEO Room, A-6-14, Vineet Khand 6,Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  919936060008  
Fax    
Email  aarti.kumar@celworld.org  
 
Details of Contact Person
Scientific Query
 
Name  Aarti Kumar 
Designation  CEO and Principal Scientist 
Affiliation  Community Empowerment Lab 
Address  Community Empowerment Lab 1st Floor, CEO Room, A-6-14, Vineet Khand 6,Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  919936060008  
Fax    
Email  aarti.kumar@celworld.org  
 
Details of Contact Person
Public Query
 
Name  Vinay Pratap Singh 
Designation  Director Research Management 
Affiliation  Community Empowerment Lab 
Address  Community Empowerment Lab Ground Floor, Research Management Room, A-6-14, Vineet Khand 6, Gomti Nagar Lucknow

Lucknow
UTTAR PRADESH
226010
India 
Phone  919818000252  
Fax    
Email  vinaypratap.singh@celworld.org  
 
Source of Monetary or Material Support  
Indian Council Of Medical Research (ICMR) V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India. 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  Indian Council of Medical Research V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India  
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
Community Empowerment Lab  F-09, 9th Floor, F-Block, Tower-B, Shalimar Grand, 10 Jopling Road, Lucknow - 226001 (India) 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 7  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ms Aarti Kumar  Community Empowerment Lab  1st Floor, CEO Room, A-6 14, Vineet Khand 6, Gomti Nagar, 226010
Lucknow
UTTAR PRADESH 
9936060009

aarti.kumar@celworld.org 
Dr Pradeep Kumar  District Women Hospital Barabanki  District Women Hospital Barabanki Lucknow Faizabaad Road 225001
Barabanki
UTTAR PRADESH 
9415461188

pradeep97k@gmail.com 
Dr Arun Kumar Arya  Ganesh Shankar Vidyarthi Memorial Medical College  Department of Paediatrics, 1st Floor, HOD Room, Hallet Hospital under GSVM Medical College, Swaroop Nagar 208002
Kanpur Nagar
UTTAR PRADESH 
9451425801

arunped253@yahoo.com 
Dr Ashok Kumar  Institute of Medical Sciences, Banaras Hindu University  IMS, Banaras Hindu University, Department of Paediatrics, 3rd Floor, Aurobindo Colony, Bhelupur 221005
Varanasi
UTTAR PRADESH 
9415300370

ashokkumar_bhu@hotmail.com 
Dr S N Singh  King George Medical University  Department of Paediatrics, Ground Floor, HOD Room, King Georges Medical University, Chowk, Lucknow-226003
Lucknow
UTTAR PRADESH 
9415196707

snsingh@kgmcindia.edu 
Prof Mala Kumar  King George Medical University  Department of Paediatrics, Ground Floor, HOD Room, King Georges Medical University, Chowk, Lucknow-226003
Lucknow
UTTAR PRADESH 
9415470555

malakumar@kgmcindia.edu 
Dr Salman Khan  Veerangana Avanti Bai Mahila Chikbagwalaitsalaya Dufferin Hospital  Hospital Rd, Golaganj, Kaiser Bagh, Lucknow, Uttar Pradesh 226018
Lucknow
UTTAR PRADESH 
8756624408

salmankhankhansalman@yahoo.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 4  
Name of Committee  Approval Status 
Banaras Hindu University Institutional Ethics Committee  Approved 
Community Empowerment Lab Institutional Ethics Committee  Approved 
Ethics Committee, GSVM Medical College Kanpur  Approved 
Institutional Ethics Committee KGMU Lucknow  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy newborns (Weighing equal or above 2500 grams at birth) without any complications born through uncomplicated vaginal deliveries in the study facility along with their nursing mothers.  
Patients  (1) ICD-10 Condition: P809||Hypothermia of newborn, unspecified,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Comparator Agent  Control Arm: Standard Facility care  Control group will receive the standard of care as per the facility norms by facility health providers. This may include basic counselling including lactation, record-keeping, general assessment, vaccinations, etc. by the nurses and doctors in the facility. The study team will supervise the provision of counselling on essential newborn care by facility nurse providers to ensure an equivalent counselling package to both the groups. This will include counselling on thermal care (without mentioning SSC), exclusive breastfeeding with basic lactation counselling, hygiene including handwashing and cord care, danger signs and care-seeking. 
Intervention  Intervention Arm: continuous and prolonged skin-to-skin contact   This intervention group will receive standard care as control group along with the intervention from the mother to the baby will include continuous and prolonged skin-to-skin contact (SSC) (ideally greater than equal to 20 hours, but at least greater than equal to 8 hours daily), along with breastfeeding on demand in the KMC position (on-demand, as initiated by the newborn as per his/her needs while in SSC) during the first 72 hours of life. Post the first 72 hours and through the newborn period, mothers will be recommended to continue with SSC as per their desire and comfort, and be advised to continue to breastfeed in the KMC position to the extent possible. 
 
Inclusion Criteria
Modification(s)  
Age From  0.00 Day(s)
Age To  27.00 Day(s)
Gender  Both 
Details  1. Healthy singleton newborns with birth weight greater than equal to 2500 grams, born vaginally and screened and enrolled within 4 hours of birth.
2.Residing within the catchment area near the study facility
3. Having singleton vaginal births in the study facility without any complications
4. Willing to stay in the study facility for 48 hours post-delivery and continue recommended practices at home post-discharge
5. Provide written informed consent for study participation within 4 (four) hours of birth.

 
 
ExclusionCriteria 
Details  Newborns:
1) Any condition that will require immediate admission to the neonatal intensive care unit (NICU/ SNCU) such as respiratory distress, birth asphyxia etc
2) Newborn should not be enrolled in any other research study that would interfere with the intervention and outcomes.
3) Having major congenital malformations which are apparent at birth that can interfere with the intervention like anencephaly, hydrocephalus, omphalocele, cleft lip, cleft palate, meningomyelocele, imperforate anus.
Mothers:
1) Maternal death
2) Multiple births
3) Caesarean section delivery
4)Women with HIV opting for top feeding
5) Any complications e.g. post partum haemorrhage (PPH), eclampsia, etc. identified within an hour of birth, requiring special or intensive care beyond routine postnatal care
6) Any other problems, such as generalized skin rashes/ infection, that may hinder their ability to provide prolonged KMC 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
1) Percentage weight change over the first 48 hours after birth.
2) The weight gain velocity during the newborn period
3) Quality of breastfeeding as measured through the Bristol Breastfeeding Assessment Tool (BBAT) score on Day 8
 
1) 48 hours of birth
2) After the newborn reaches 28 days of age
3) After the newborn reaches 28 days of age
 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
Exclusive Breastfeeding at day 28 of birth  After the newborn reaches 28 days of age 
Score on the Breastfeeding Experience Scale as reported by mother  At 8 days of birth 
Possible Serious Bacterial Infection (PSBI) among infants  4, 8, 15 & 29 days of birth.  
Maternal depression measured at 15days after birth  At the age of 15 days 
Mother-to-infant bonding scale measured on day 29  After the newborn reaches 28 days of age 
Breastfeeding self-efficacy scale (short form) measured on day 29  After the newborn reaches 28 days of age 
 
Target Sample Size   Total Sample Size="516"
Sample Size from India="516" 
Final Enrollment numbers achieved (Total)= "523"
Final Enrollment numbers achieved (India)="523" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   15/11/2024 
Date of Study Completion (India) 20/02/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [aarti.kumar@celworld.org].

  6. For how long will this data be available start date provided 01-04-2025 and end date provided 31-03-2030?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

Suboptimal breastfeeding practices within the first week of an infants life may perpetuate a deleterious cycle of inadequate lactation and stunted growth. The initial challenges in thermoregulation and metabolism during the transition from intrauterine to extrauterine life within the initial 72 hours can also contribute to early weight loss in neonates. Kangaroo Mother Care (KMC) is a recommended practice for reducing mortality in low birth weight infants, and it may potentially enhance nutritional and growth outcomes in normal birth weight infants when initiated within the first 72 hours of life.

This multicenter, open-label, two-arm, individually randomized controlled trial will enroll infants born with a birth weight of 2500 grams or higher, without delivery complications. A total of 516 infants will be randomly assigned to either the intervention or control groups. Infants in the intervention group will receive extended KMC for the initial 48 hours, while control group infants will receive standard breastfeeding counseling. Assessments will be conducted on days 1, 2, 4, 7, 15, and 28 to evaluate study outcomes.

Kangaroo Mother Care (KMC) is a cost-effective innovation that involves skin-to-skin contact between the newborn and the mother or caregiver, combined with exclusive breastfeeding and additional supportive care. When KMC is initiated after clinical stability is achieved, it results in a 40% improved survival rate compared to traditional incubator care. Furthermore, when KMC is initiated before clinical stabilization, it accelerates the stabilization process and reduces neonatal mortality by an additional 25% compared to conventional incubator care before stabilization. This study in Uttar Pradesh is part of a broader multicenter initiative, involving multiple sites and close collaboration with the health system, research teams, and community stakeholders. The study in UP will be conducted in partnership with medical colleges, where obstetric and pediatric leadership will lead the integration of KMC within their facilities and support its wider adoption. The study will also require strong coordination with lower-level facilities to facilitate the early initiation of KMC for term, normal-weight infants.

In this study, we will enroll 516 singleton neonates with normal birth weight, defined as infants weighing 2500 grams or more at birth within the study facility. Following screening, infants will be randomized to the intervention or control groups immediately after birth, with randomization achieved through a concealed allocation based on a computer-generated sequence. Each motherinfant pair will receive a unique identification number. 

Mothers of infants in the intervention group will receive education and counseling immediately after birth, emphasizing prolonged skin-to-skin contact in the KMC position during the initial 72 hours of life. This involves maintaining skin-to-skin contact for a minimum of 8 hours per day during their facility stay, along with on-demand breastfeeding. The duration of skin-to-skin contact can gradually extend and continue as long as the baby remains comfortable. Both the infant and mother will remain bare-chested in the KMC position, with the baby head covered by a cap and feet kept warm with socks. In the control group, mother-infant pairs will receive standard care, including general counseling on early and exclusive breastfeeding after birth. 

We anticipate that early implementation of KMC has the potential to significantly enhance nutritional and growth outcomes in infants under 6 months and contribute to the standardization of newborn care protocols across different weight categories.

 
Close